Jia Yi Tan

10PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsPacific Peoples epidemiologyMortality
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 22, 2026
Real-world outcomes of cilta-cel versus BCMA-targeting bispecific antibodies in relapsed/refractory multiple myeloma.

|Apr 28, 2026
Outcomes of extended reduced-dose apixaban versus full-dose apixaban in cancer-associated venous thromboembolism.

|Oct 30, 2025
Impact of Age on Early CAR T-Cell Therapy Toxicity: A Propensity Score Matching Analysis.

Jia Yi Tan, Yong-Hao Yeo, Qi Xuan Ang

|Jul 22, 2025
SGLT2 inhibitors and cardiovascular outcomes in patients with multiple myeloma and concomitant type 2 diabetes mellitus.

Jia Yi Tan, Aravinthan Vignarajah, Yong Hao Yeo

|Jul 02, 2025
Cancer Among Asian Americans and Pacific Islanders, 1999-2020.

Jia Yi Tan, Xuan Ci Mee, Wan Ying Tan

|Mar 25, 2025
Sex Differences in Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy.

Jia Yi Tan, Yong Hao Yeo, Hermon Wong Kha Kin

Pageof 2

Frequent Collaborators

5 joint publications

Yong-Hao Yeo

2 joint publications

Mohammad Muhsin Chisti

2 joint publications

Talal Hilal

2 joint publications

Aravinthan Vignarajah